Fanconi Anemia Stem Cell Treatments

Innovative Cellular Therapy for Bone Marrow Failure

Fanconi Anemia (FA) is a rare-inherited disorder that affects the bone marrow, leading to a decreased production of all types of blood cells. This condition increases the risk of bone marrow failure, leukemia, and other serious complications.

At 1 STEM CELL, we provide advanced stem cell therapy designed to support bone marrow function and improve overall hematopoietic (blood-forming) activity. Our treatment protocols use umbilical cord-derived mesenchymal stem cells (MSCs), known for their regenerative and immunomodulatory properties, to promote cellular repair and enhance the production of healthy blood cells.

This regenerative approach aims to reduce the need for frequent transfusions and minimize complications associated with bone marrow failure, offering a potential alternative or complement to traditional treatments such as bone marrow transplantation.

Questions and Answers About Fanconi Anemia Stem Cell Treatments

Q: How does stem cell therapy help patients with Fanconi Anemia?

Stem cells can restore and stabilize bone marrow function by differentiating into healthy cells and releasing growth factors that stimulate the regeneration of blood-producing tissues.

Q: Is this treatment a cure for Fanconi Anemia?

Currently, stem cell therapy is not a definitive cure but can significantly improve quality of life by supporting hematopoietic activity and reducing related symptoms.

Q: What type of stem cells are used?

We use mesenchymal stem cells (MSCs) obtained from ethically sourced umbilical cords, processed under strict laboratory standards to ensure purity and safety.

Q: Who is eligible for this therapy?

Patients diagnosed with Fanconi Anemia who are experiencing bone marrow failure or complications related to blood cell production may be considered candidates after medical evaluation.

Q: How is the procedure performed?

The therapy is minimally invasive. Stem cells are administered intravenously under clinical supervision, allowing them to travel to the bone marrow and begin the regenerative process.